176 related articles for article (PubMed ID: 24597503)
1. Modular plasmonic nanocarriers for efficient and targeted delivery of cancer-therapeutic siRNA.
Huang X; Pallaoro A; Braun GB; Morales DP; Ogunyankin MO; Zasadzinski J; Reich NO
Nano Lett; 2014; 14(4):2046-51. PubMed ID: 24597503
[TBL] [Abstract][Full Text] [Related]
2. Evaluating the Mechanisms of Light-Triggered siRNA Release from Nanoshells for Temporal Control Over Gene Regulation.
Riley RS; Dang MN; Billingsley MM; Abraham B; Gundlach L; Day ES
Nano Lett; 2018 Jun; 18(6):3565-3570. PubMed ID: 29701993
[TBL] [Abstract][Full Text] [Related]
3. Gene silencing by gold nanoshell-mediated delivery and laser-triggered release of antisense oligonucleotide and siRNA.
Huschka R; Barhoumi A; Liu Q; Roth JA; Ji L; Halas NJ
ACS Nano; 2012 Sep; 6(9):7681-91. PubMed ID: 22862291
[TBL] [Abstract][Full Text] [Related]
4. Anisamide-targeted PEGylated gold nanoparticles designed to target prostate cancer mediate: Enhanced systemic exposure of siRNA, tumour growth suppression and a synergistic therapeutic response in combination with paclitaxel in mice.
Luan X; Rahme K; Cong Z; Wang L; Zou Y; He Y; Yang H; Holmes JD; O'Driscoll CM; Guo J
Eur J Pharm Biopharm; 2019 Apr; 137():56-67. PubMed ID: 30779980
[TBL] [Abstract][Full Text] [Related]
5. A Dual Targeting Dendrimer-Mediated siRNA Delivery System for Effective Gene Silencing in Cancer Therapy.
Dong Y; Yu T; Ding L; Laurini E; Huang Y; Zhang M; Weng Y; Lin S; Chen P; Marson D; Jiang Y; Giorgio S; Pricl S; Liu X; Rocchi P; Peng L
J Am Chem Soc; 2018 Nov; 140(47):16264-16274. PubMed ID: 30346764
[TBL] [Abstract][Full Text] [Related]
6. Bioconjugated Gold Nanoparticles Enhance siRNA Delivery in Prostate Cancer Cells.
Rahme K; Guo J; Holmes JD
Methods Mol Biol; 2019; 1974():291-301. PubMed ID: 31099011
[TBL] [Abstract][Full Text] [Related]
7. Bioconjugated gold nanoparticles enhance cellular uptake: A proof of concept study for siRNA delivery in prostate cancer cells.
Guo J; O'Driscoll CM; Holmes JD; Rahme K
Int J Pharm; 2016 Jul; 509(1-2):16-27. PubMed ID: 27188645
[TBL] [Abstract][Full Text] [Related]
8. In vivo sustained release of siRNA from solid lipid nanoparticles.
Lobovkina T; Jacobson GB; Gonzalez-Gonzalez E; Hickerson RP; Leake D; Kaspar RL; Contag CH; Zare RN
ACS Nano; 2011 Dec; 5(12):9977-83. PubMed ID: 22077198
[TBL] [Abstract][Full Text] [Related]
9. Nanoparticle-enabled, image-guided treatment planning of target specific RNAi therapeutics in an orthotopic prostate cancer model.
Lin Q; Jin CS; Huang H; Ding L; Zhang Z; Chen J; Zheng G
Small; 2014 Aug; 10(15):3072-82. PubMed ID: 24706435
[TBL] [Abstract][Full Text] [Related]
10. Acid-degradable polymer-caged lipoplex (PCL) platform for siRNA delivery: facile cellular triggered release of siRNA.
Hong BJ; Chipre AJ; Nguyen ST
J Am Chem Soc; 2013 Nov; 135(47):17655-8. PubMed ID: 24000948
[TBL] [Abstract][Full Text] [Related]
11. Systemic delivery of therapeutic small interfering RNA using a pH-triggered amphiphilic poly-L-lysine nanocarrier to suppress prostate cancer growth in mice.
Guo J; Cheng WP; Gu J; Ding C; Qu X; Yang Z; O'Driscoll C
Eur J Pharm Sci; 2012 Apr; 45(5):521-32. PubMed ID: 22186295
[TBL] [Abstract][Full Text] [Related]
12. Folate-targeted amphiphilic cyclodextrin nanoparticles incorporating a fusogenic peptide deliver therapeutic siRNA and inhibit the invasive capacity of 3D prostate cancer tumours.
Evans JC; Malhotra M; Sweeney K; Darcy R; Nelson CC; Hollier BG; O'Driscoll CM
Int J Pharm; 2017 Oct; 532(1):511-518. PubMed ID: 28916296
[TBL] [Abstract][Full Text] [Related]
13. Enhanced siRNA delivery and silencing gold-chitosan nanosystem with surface charge-reversal polymer assembly and good biocompatibility.
Han L; Zhao J; Zhang X; Cao W; Hu X; Zou G; Duan X; Liang XJ
ACS Nano; 2012 Aug; 6(8):7340-51. PubMed ID: 22838646
[TBL] [Abstract][Full Text] [Related]
14. Conjugates of HA2 with octaarginine-grafted HPMA copolymer offer effective siRNA delivery and gene silencing in cancer cells.
Golan M; Feinshtein V; David A
Eur J Pharm Biopharm; 2016 Dec; 109():103-112. PubMed ID: 27702685
[TBL] [Abstract][Full Text] [Related]
15. Development of elastin-like polypeptide for targeted specific gene delivery in vivo.
Yi A; Sim D; Lee YJ; Sarangthem V; Park RW
J Nanobiotechnology; 2020 Jan; 18(1):15. PubMed ID: 31952530
[TBL] [Abstract][Full Text] [Related]
16. Novel epithelial cell adhesion molecule antibody conjugated polyethyleneimine-capped gold nanoparticles for enhanced and targeted small interfering RNA delivery to retinoblastoma cells.
Mitra M; Kandalam M; Rangasamy J; Shankar B; Maheswari UK; Swaminathan S; Krishnakumar S
Mol Vis; 2013; 19():1029-38. PubMed ID: 23687439
[TBL] [Abstract][Full Text] [Related]
17. Acoustic Cavitation-Mediated Delivery of Small Interfering Ribonucleic Acids with Phase-Shift Nano-Emulsions.
Burgess MT; Porter TM
Ultrasound Med Biol; 2015 Aug; 41(8):2191-201. PubMed ID: 25979417
[TBL] [Abstract][Full Text] [Related]
18. Improved intracellular delivery of peptide- and lipid-nanoplexes by natural glycosides.
Weng A; Manunta MD; Thakur M; Gilabert-Oriol R; Tagalakis AD; Eddaoudi A; Munye MM; Vink CA; Wiesner B; Eichhorst J; Melzig MF; Hart SL
J Control Release; 2015 May; 206():75-90. PubMed ID: 25758332
[TBL] [Abstract][Full Text] [Related]
19. Enhancing endosomal escape for nanoparticle mediated siRNA delivery.
Ma D
Nanoscale; 2014 Jun; 6(12):6415-25. PubMed ID: 24837409
[TBL] [Abstract][Full Text] [Related]
20. Light-activated RNA interference in human embryonic stem cells.
Huang X; Hu Q; Braun GB; Pallaoro A; Morales DP; Zasadzinski J; Clegg DO; Reich NO
Biomaterials; 2015 Sep; 63():70-9. PubMed ID: 26086448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
